Suresh K. Durgam

Companies

• Intra-Cellular Therapies, Inc.Chief Medical Officer Oct 28, 2020 to Apr 2, 2025¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ICIntra-Cellular Therapies, Inc.0 shares²Apr 2, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 2, 2025Returned to company 42,913 shares at $132.00 of Intra-Cellular Therapies, Inc.²
• Mar 10, 2025Shares withheld for tax 3,116 shares at $131.24 of Intra-Cellular Therapies, Inc.³
• Mar 10, 2025Exercised options 7,345 shares of Intra-Cellular Therapies, Inc.³
• Mar 6, 2025Shares withheld for tax 5,572 shares at $131.19 of Intra-Cellular Therapies, Inc.³
• Mar 6, 2025Exercised options 13,133 shares of Intra-Cellular Therapies, Inc.³
• Mar 1, 2025Shares withheld for tax 3,709 shares at $128.20 of Intra-Cellular Therapies, Inc.⁴
• Mar 1, 2025Exercised options 8,742 shares of Intra-Cellular Therapies, Inc.⁴
• Jan 31, 2025Shares withheld for tax 4,730 shares at $127.00 of Intra-Cellular Therapies, Inc.⁵
• Jan 31, 2025Granted 11,017 shares of Intra-Cellular Therapies, Inc.⁵
• Mar 11, 2024Sold 661 shares at $66.96 of Intra-Cellular Therapies, Inc.⁶
• Mar 11, 2024Sold 872 shares at $65.89 of Intra-Cellular Therapies, Inc.⁶
• Mar 11, 2024Sold 2,179 shares at $65.06 of Intra-Cellular Therapies, Inc.⁶
• Mar 10, 2024Exercised options 7,345 shares of Intra-Cellular Therapies, Inc.⁶
• Mar 7, 2024Sold 2,722 shares at $66.86 of Intra-Cellular Therapies, Inc.⁶
• Mar 7, 2024Sold 3,728 shares at $66.34 of Intra-Cellular Therapies, Inc.⁶
• Mar 6, 2024Exercised options 13,132 shares of Intra-Cellular Therapies, Inc.⁷
• Feb 26, 2024Sold 1,312 shares at $71.02 of Intra-Cellular Therapies, Inc.⁸
• Feb 26, 2024Sold 1,400 shares at $70.16 of Intra-Cellular Therapies, Inc.⁸
• Feb 26, 2024Sold 1,400 shares at $69.38 of Intra-Cellular Therapies, Inc.⁸
• Feb 23, 2024Exercised options 7,907 shares of Intra-Cellular Therapies, Inc.⁸
• Feb 2, 2024Sold 3,847 shares at $67.49 of Intra-Cellular Therapies, Inc.⁹
• Feb 2, 2024Sold 2,320 shares at $66.69 of Intra-Cellular Therapies, Inc.⁹
• Feb 1, 2024Granted 11,860 shares of Intra-Cellular Therapies, Inc.⁹
• Jan 2, 2024Sold 2,210 shares at $71.77 of Intra-Cellular Therapies, Inc.¹⁰
• Jan 2, 2024Sold 22,645 shares at $70.80 of Intra-Cellular Therapies, Inc.¹⁰